Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03537898 · ClinicalTrials.gov registry record · NA
Balanced Solutions and Plasma Electrolytes
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2,093
- Enrollment target
NCT03537898 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 2,093 participants.
The verdict
NCT03537898, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,093 participants
- Enrollment target
Study Summary
The administration of intravenous fluids is ubiquitous in the care of the critically ill. Commonly available isotonic crystalloid solutions contain a broad spectrum electrolyte compositions including a range chloride concentrations. Recent prospective, randomized trials have shown improved patient outcomes with the use of balanced crystalloids compared to saline. There have not been large randomized studies comparing acetate buffered balanced crystalloids to non-acetate buffered balanced crystalloids in the critically ill. BASE will be a pilot study for a large, cluster-randomized, multiple-crossover trial enrolling critically ill patients from the Medical ICU at Vanderbilt University from June 2018 until January 2019. The primary endpoint will be plasma bicarbonate concentration between Intensive Care Unit admission and hospital discharge.
Interventions
- OTHER Lactated Ringer's
- OTHER Normosol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,093 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2019-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03537898
The ClinicalTrials.gov registry entry for NCT03537898 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,093 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lactated Ringer's is the first listed.
NCT03537898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03537898 about?
NCT03537898 is a clinical study titled "Balanced Solutions and Plasma Electrolytes". The administration of intravenous fluids is ubiquitous in the care of the critically ill. Commonly available isotonic crystalloid solutions contain a broad spectrum electrolyte compositions including a range chloride concentrations. Recent prospective, randomized trials have shown improved patient o...
What is the current status of trial NCT03537898?
This trial is currently completed. It is a NA study. The enrollment target is 2,093 participants. The study started on 2018-06-01. Estimated completion is 2019-03-02.
What interventions are being tested in trial NCT03537898?
The interventions under investigation include: Lactated Ringer's (OTHER), Normosol (OTHER).
Who is sponsoring clinical trial NCT03537898?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.